Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
Combining Dynamic Biosensors’ Innovative Technologies with Bruker’s High-Performance SPR Portfolio to Establish a Leading Biosensors Business
Advertisement
Bruker Corporation announced the acquisition of Dynamic biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker’s biophysical portfolio for the analysis of Molecular Interactions and kinetics, offering deeper insights into both inter-molecular and molecule-single cell interactions in drug discovery or basic research.
Dynamic Biosensors (DBS) develops and markets innovative technologies for studying complex molecular interactions and kinetics, supporting drug discovery in the pharma and biotech industries, as well as in basic and medical research. The new Dynamic Biosensors heli X cyto instrument performs single-cell Interaction Cytometry (scIC) for kinetic measurements directly on cells, retaining the molecules’ native membrane environment. The heli X + instrument utilizes switch SENSE ® technology, employing DNA nanolevers to functionalize molecules of interest on the chip surface to characterize their binding behavior and kinetics, as well as conformational changes. In combination with Bruker’s high-throughput Surface Plasmon Resonance (SPR) portfolio, which includes the all-new SPR #64 ‘Triceratops’ , and the 24- and 32-spot Sierra-Pro SPR systems, the combined Bruker Biosensors business now offers one of the most innovative range of instruments, workflows, and consumables for studying inter-molecular and molecule-cell interactions in the drug discovery pipeline.
Financial details of the transaction were not disclosed. In FY2025, Bruker Biosensors expects additional revenues greater than $5 million from the DBS acquisition, with no material EPS impact.
Other news from the department business & finance
These products might interest you
Octet R2 / Octet R4 / Octet R8 by Sartorius
Full power on 2, 4 or 8 channels: Label-free and GxP-compliant analysis of molecular interactions
Innovative label-free real-time protein quantification, binding kinetics and rapid screenings
Octet RH16 and RH96 by Sartorius
Efficient protein analysis for process optimisation and manufacturing control in high-throughput
Label-free protein quantification and characterization of protein-protein interactions
Octet SF3 by Sartorius
Surface Plasmon Resonance (SPR) using Single Dynamic Injections for Kinetics and Affinities
Curvature is Key - Adding a ‘Third Dimension’ to the Binding Curve
